[go: up one dir, main page]

CN113845491A - Benzophenothiazine derivatives and process for their preparation - Google Patents

Benzophenothiazine derivatives and process for their preparation Download PDF

Info

Publication number
CN113845491A
CN113845491A CN202111061758.2A CN202111061758A CN113845491A CN 113845491 A CN113845491 A CN 113845491A CN 202111061758 A CN202111061758 A CN 202111061758A CN 113845491 A CN113845491 A CN 113845491A
Authority
CN
China
Prior art keywords
benzophenothiazine
preparation
complex
present
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202111061758.2A
Other languages
Chinese (zh)
Inventor
许文娟
张清源
王鹤然
房维佳
密保秀
黄维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Posts and Telecommunications
Original Assignee
Nanjing University of Posts and Telecommunications
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Posts and Telecommunications filed Critical Nanjing University of Posts and Telecommunications
Priority to CN202111061758.2A priority Critical patent/CN113845491A/en
Publication of CN113845491A publication Critical patent/CN113845491A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/36[b, e]-condensed, at least one with a further condensed benzene ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1037Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

本发明涉及一类新型苯并吩噻嗪衍生物及制备方法。本发明以苯并吩噻嗪作为给电子基团,在吩噻嗪的氮原子上共价键接电子受体基团,结构通式如下式a或b所示:

Figure DDA0003256636680000011
该材料中的受体基团与苯并吩噻嗪单元间形成扭曲的分子骨架,形成分离的最高占有分子轨道(HOMO)和最低未占有分子轨道排布(LUMO),因此具有高效的分子内电荷转移跃迁,并且分离的HOMO和LUMO轨道有利于减小△EST,从而产生有效的热激活延迟荧光。结构稳定、原料普通易得、生产成本低。本发明的苯并吩噻嗪衍生物应用于有机电致发光器件中,具有高的发光效率。

Figure 202111061758

The present invention relates to a new class of benzophenothiazine derivatives and a preparation method. In the present invention, benzophenothiazine is used as an electron-donating group, and an electron-accepting group is covalently bonded to the nitrogen atom of phenothiazine, and the general structural formula is shown in the following formula a or b:

Figure DDA0003256636680000011
The acceptor group in this material forms a twisted molecular framework with the benzophenothiazine unit, forming the separated highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital arrangement (LUMO), so it has efficient intramolecular charge-transfer transitions, and the separated HOMO and LUMO orbitals favorably reduce ΔEST, resulting in efficient thermally activated delayed fluorescence. The structure is stable, the raw materials are common and easy to obtain, and the production cost is low. The benzophenothiazine derivatives of the present invention are used in organic electroluminescence devices and have high luminous efficiency.

Figure 202111061758

Description

苯并吩噻嗪衍生物及制备方法Benzophenothiazine derivatives and preparation method thereof

技术领域technical field

本发明属于有机光电功能材料技术领域,具体涉及一类苯并吩噻嗪衍生物及制备方法。The invention belongs to the technical field of organic photoelectric functional materials, in particular to a class of benzophenothiazine derivatives and a preparation method.

背景技术Background technique

有机发光二极管(OLED)是利用有机材料把电能转化为光的器件,有机发光材料是柔性显示技术的基础核心物质。柔性OLED是实现曲面显示,乃至未来柔性显示的基础。OLED具有显示自发光特点,使其对比度、黑场表现、色域、响应速度、可视角度相较于目前市面主流的LED液晶显示均有革命性提升,OLED作为新一代显示技术,显示结构简单、耗材环保,且OLED显示具有柔性可卷曲的特点,更方便运输和安装,突破尺寸的限制,规模化量产后更有可能具备低成本普及的优势。Organic light-emitting diodes (OLEDs) are devices that use organic materials to convert electrical energy into light. Organic light-emitting materials are the basic core material of flexible display technology. Flexible OLED is the basis for realizing curved display and even future flexible display. OLED has the characteristics of display self-luminescence, which makes its contrast ratio, black field performance, color gamut, response speed, and viewing angle all revolutionary compared with the current mainstream LED liquid crystal display on the market. As a new generation of display technology, OLED has a simple display structure. , The consumables are environmentally friendly, and the OLED display has the characteristics of flexibility and rollability, which is more convenient for transportation and installation, breaking through the limitation of size, and it is more likely to have the advantage of low-cost popularization after large-scale mass production.

有机发光材料是有机电致发光的核心技术,也是该领域研究以及竞争的焦点。目前有机发光二极管的发光材料主要是磷光材料,以铱配合物为主要代表。由于金属配合物磷光材料中的贵金属(如铱、铂等)资源稀缺,价格昂贵,也大大的限制了它们的进一步发展和应用。因此兼具低成本,高发光效率,高激子利用率的新一代有机电致发光材料分子的设计,是近年来有机发光二极管领域的一个重要课题。Organic light-emitting materials are the core technology of organic electroluminescence, and are also the focus of research and competition in this field. At present, the light-emitting materials of organic light-emitting diodes are mainly phosphorescent materials, mainly represented by iridium complexes. Due to the scarcity and high price of precious metals (such as iridium, platinum, etc.) in metal complex phosphorescent materials, their further development and applications are greatly limited. Therefore, the design of a new generation of organic electroluminescent material molecules with low cost, high luminous efficiency and high exciton utilization rate is an important topic in the field of organic light emitting diodes in recent years.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一类结构稳定、原料普通易得、生产成本低、具有高的荧光量子效率、高热稳定性及高分子内电荷转移的一类苯并吩噻嗪衍生物延迟荧光材料及其制备方法。The object of the present invention is to provide a class of benzophenothiazine derivative delayed fluorescent materials with stable structure, common and readily available raw materials, low production cost, high fluorescence quantum efficiency, high thermal stability and charge transfer in the polymer and its preparation method.

为达到上述目的,本发明采用的技术方案如下:For achieving the above object, the technical scheme adopted in the present invention is as follows:

一方面,一种苯并吩噻嗪衍生物,其结构通式如下式a或b所示:In one aspect, a benzophenothiazine derivative, the general structural formula of which is shown in the following formula a or b:

Figure BDA0003256636660000021
Figure BDA0003256636660000021

其中,

Figure BDA0003256636660000022
选自以下结构式中的任一种:in,
Figure BDA0003256636660000022
is selected from any one of the following structural formulas:

Figure BDA0003256636660000023
Figure BDA0003256636660000023

另一方面,前述的式a或b所示的苯并吩噻嗪衍生物的制备方法,包括:以苯并吩噻嗪作为电子供体单元,与电子受体单元在吩噻嗪的氮原子上发生共价键接合,所述电子受体单元选自4-溴苯腈、(4-溴苯基)[双(2,4,6-三甲基苯基)]硼烷、5-溴-1,3-苯二腈、2-4-溴苯基-4,6-二苯基-1,3,5-三嗪中的任一种。On the other hand, the preparation method of the benzophenothiazine derivative represented by the aforementioned formula a or b comprises: using the benzophenothiazine as the electron donor unit, and the electron acceptor unit at the nitrogen atom of the phenothiazine Covalent bonding occurs on the electron acceptor unit selected from 4-bromobenzonitrile, (4-bromophenyl)[bis(2,4,6-trimethylphenyl)]borane, 5-bromophenyl -1,3-phthalonitrile and 2-4-bromophenyl-4,6-diphenyl-1,3,5-triazine.

进一步地,所述电子供体单元为

Figure BDA0003256636660000031
Figure BDA0003256636660000032
Further, the electron donor unit is
Figure BDA0003256636660000031
Figure BDA0003256636660000032

进一步地,式a所示苯并吩噻嗪衍生物的制备方法,合成路线如下:Further, the preparation method of benzophenothiazine derivative shown in formula a, the synthetic route is as follows:

Figure BDA0003256636660000033
Figure BDA0003256636660000033

其中,

Figure BDA0003256636660000034
为以下结构式中的任一种:in,
Figure BDA0003256636660000034
is any of the following structural formulas:

Figure BDA0003256636660000035
Figure BDA0003256636660000035

进一步地,式a所示苯并吩噻嗪衍生物的制备方法,包括以下步骤:Further, the preparation method of benzophenothiazine derivative shown in formula a, comprises the following steps:

将2-氨基苯硫醇和1-四氢萘酮溶解在二甲基亚砜中,在110℃下反应24h后提纯得到相应的苯并吩噻嗪配合物1;The corresponding benzophenothiazine complex 1 was obtained by dissolving 2-aminobenzenethiol and 1-tetralone in dimethyl sulfoxide and reacting at 110 °C for 24 h after purification;

将苯并吩噻嗪配合物1、化合物

Figure BDA0003256636660000036
叔丁醇钠、三(二亚苄基丙酮)二钯、四氟硼酸三叔丁基膦溶解于甲苯中,在氮气保护下反应13h后分离提纯得到。The benzophenothiazine complex 1, compound
Figure BDA0003256636660000036
Sodium tert-butoxide, tris(dibenzylideneacetone)dipalladium and tri-tert-butylphosphine tetrafluoroborate were dissolved in toluene, reacted under nitrogen protection for 13h, and obtained by separation and purification.

进一步地,式b所示苯并吩噻嗪衍生物的制备方法,合成路线如下:Further, the preparation method of benzophenothiazine derivative shown in formula b, the synthetic route is as follows:

Figure BDA0003256636660000041
Figure BDA0003256636660000041

其中,

Figure BDA0003256636660000042
为以下结构式中的任一种:in,
Figure BDA0003256636660000042
is any of the following structural formulas:

Figure BDA0003256636660000043
Figure BDA0003256636660000043

进一步地,式b所示苯并吩噻嗪衍生物的制备方法,包括以下步骤:Further, the preparation method of benzophenothiazine derivative shown in formula b, comprises the following steps:

将化合物1、硫和碘混合物加热至180-185℃,在该温度反应25分钟分离提纯得到相应的苯并吩噻嗪配合物2;Compound 1, sulfur and iodine mixture are heated to 180-185°C, and react at this temperature for 25 minutes to separate and purify to obtain the corresponding benzophenothiazine complex 2;

将苯并吩噻嗪配合物2、化合物

Figure BDA0003256636660000044
叔丁醇钠、三(二亚苄基丙酮)二钯,四氟硼酸三叔丁基膦溶解于甲苯中,在氮气保护下反应13h后分析提纯得到。The benzophenothiazine complex 2, compound
Figure BDA0003256636660000044
Sodium tert-butoxide, tris(dibenzylideneacetone)dipalladium, and tri-tert-butylphosphine tetrafluoroborate were dissolved in toluene, reacted for 13h under nitrogen protection, and obtained by analysis and purification.

本发明所达到的有益技术效果:Beneficial technical effect achieved by the present invention:

本发明的苯并吩噻嗪衍生物以吩噻嗪为电子给体,可抑制分子间的紧密堆积,提高荧光性能。键接三芳基硼、氰基苯等强电子受体,可以发挥很强的LUMO定位作用,提高分子内电荷转移,具有高发光效率,引入苯环可以提高平面共轭,进一步拓宽光谱响应范围,发射红移。此外,本发明具有结构稳定、原料普通易得、生产成本低、高热稳定性的优点。The benzophenothiazine derivatives of the present invention use phenothiazine as an electron donor, which can inhibit the close packing between molecules and improve the fluorescence performance. Bonded with strong electron acceptors such as triarylboron and cyanobenzene, it can exert a strong LUMO localization effect, improve intramolecular charge transfer, and have high luminous efficiency. The introduction of benzene ring can improve plane conjugation and further broaden the spectral response range. Emission redshift. In addition, the present invention has the advantages of stable structure, common and readily available raw materials, low production cost and high thermal stability.

附图说明Description of drawings

图1本发明实施例3中制备的苯并吩噻嗪衍生物的吸收光谱示意图;1 is a schematic diagram of the absorption spectrum of the benzophenothiazine derivative prepared in Example 3 of the present invention;

图2本发明实施例4中制备的苯并吩噻嗪衍生物的吸收光谱示意图;2 is a schematic diagram of the absorption spectrum of the benzophenothiazine derivative prepared in Example 4 of the present invention;

图3本发明实施例3中制备的苯并吩噻嗪衍生物的发射光谱示意图;Figure 3 is a schematic diagram of the emission spectrum of the benzophenothiazine derivative prepared in Example 3 of the present invention;

图4本发明实施例4中制备的苯并吩噻嗪衍生物的发射光谱示意图;Figure 4 is a schematic diagram of the emission spectrum of the benzophenothiazine derivative prepared in Example 4 of the present invention;

图5本发明实施例4中制备的苯并吩噻嗪衍生物中间体的TGA图谱。Fig. 5 TGA spectrum of the benzophenothiazine derivative intermediate prepared in Example 4 of the present invention.

图6本发明实施例4中制备的苯并吩噻嗪衍生物的TGA图谱。Fig. 6 TGA spectrum of the benzophenothiazine derivative prepared in Example 4 of the present invention.

具体实施方式Detailed ways

下面结合具体实施例对本发明作进一步描述。以下实施例仅用于更加清楚地说明本发明的技术方案,而不能以此来限制本发明的保护范围。The present invention will be further described below in conjunction with specific embodiments. The following examples are only used to illustrate the technical solutions of the present invention more clearly, and cannot be used to limit the protection scope of the present invention.

本发明原理:苯并吩噻嗪配合物分子中的氮和硫原子都属于富电子原子,因此吩噻嗪基团表现出了很好的给电子能力。基团中的杂原子呈现sp3杂化使得六元环形成150°的二面角,从而吩噻嗪分子具有独特“蝴蝶型”空间结构,使得分子保有一定刚性的同时也不失柔性,这种结构还能够抑制分子间的紧密堆积,提高荧光性能。苯并吩噻嗪进一步提高了平面共轭性,拓宽光谱范围。在苯并吩噻嗪基团共价键接电子受体基团形成扭曲的分子骨架,得到分离的最高占有分子轨道(HOMO)和最低未占有分子轨道排布(LUMO),因此具有高效的分子内电荷转移跃迁,并且分离的HOMO和LUMO轨道有利于减小△EST,从而产生有效的热激活延迟荧光以应用于有机电致发光领域中。Principle of the present invention: The nitrogen and sulfur atoms in the molecule of the benzophenothiazine complex are electron-rich atoms, so the phenothiazine group exhibits a good electron donating ability. The heteroatom in the group presents sp 3 hybridization, which makes the six-membered ring form a dihedral angle of 150°, so that the phenothiazine molecule has a unique "butterfly-shaped" spatial structure, which makes the molecule retain a certain rigidity and flexibility. This structure can also inhibit the close packing between molecules and improve the fluorescence performance. Benzophenothiazine further improves the planar conjugation and broadens the spectral range. The electron acceptor group is covalently bonded to the benzophenothiazine group to form a twisted molecular skeleton, resulting in the separation of the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital arrangement (LUMO), thus possessing highly efficient molecular The internal charge transfer transition, and the separated HOMO and LUMO orbitals are beneficial to reduce ΔE ST , resulting in efficient thermally activated delayed fluorescence for application in the field of organic electroluminescence.

下面给出具体实施例:Specific examples are given below:

实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。If the specific conditions are not indicated in the examples, it is carried out according to the conventional conditions or the conditions suggested by the manufacturer. The reagents or instruments used without the manufacturer's indication are conventional products that can be purchased from the market.

实施例1:Example 1:

Figure BDA0003256636660000061
Figure BDA0003256636660000061

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000071
Figure BDA0003256636660000071

将2-氨基苯硫醇(0.75g,6mmol)和1-四氢萘酮(0.584g,4mmol),在DMSO(16.0mL)中的混合溶液在110℃下在空气中搅拌24小时。完成后,将反应混合物用乙酸乙酯(64.0mL)稀释,过滤。真空除去挥发物,得到粗产物。进一步硅胶柱色谱法(EtOAc/石油醚)分离提纯得到苯并吩噻嗪1。产率:87%。1H NMR(400MHz,Chloroform-d)δ9.58(s,2H),7.89–7.80(m,2H),7.76–7.69(m,2H),7.64(dd,J=7.4,1.5Hz,2H),7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).A mixed solution of 2-aminobenzenethiol (0.75 g, 6 mmol) and 1-tetralone (0.584 g, 4 mmol) in DMSO (16.0 mL) was stirred at 110° C. in air for 24 hours. Upon completion, the reaction mixture was diluted with ethyl acetate (64.0 mL) and filtered. The volatiles were removed in vacuo to give the crude product. Further separation and purification by silica gel column chromatography (EtOAc/petroleum ether) gave benzophenothiazine 1. Yield: 87%. 1 H NMR (400MHz, Chloroform-d) δ9.58(s, 2H), 7.89-7.80(m, 2H), 7.76-7.69(m, 2H), 7.64(dd, J=7.4, 1.5Hz, 2H) ,7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).

Figure BDA0003256636660000072
Figure BDA0003256636660000072

在圆底烧瓶中加入苯并吩噻嗪1(1.246g,5mmo1),4-溴苯腈(1.092g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料2。产率:80%。1H NMR(400MHz,Chloroform-d)δ8.01–7.92(m,1H),7.81–7.72(m,1H),7.72–7.62(m,3H),7.57–7.46(m,2H),7.37–7.30(m,3H),7.29(dd,J=7.3,1.5Hz,1H),7.22(td,J=7.4,1.6Hz,1H),7.18–7.09(m,2H).In a round-bottomed flask, add benzophenothiazine 1 (1.246g, 5mmol), 4-bromobenzonitrile (1.092g, 6mmol), sodium tert-butoxide (2.76g, 15mmol), tris(dibenzylideneacetone) Dipalladium (92 mg, 0.1 mmol), tri-tert-butylphosphine tetrafluoroborate (0.146 g, 0.5 mmol), 25 mL of toluene. Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 2. Yield: 80%. 1 H NMR(400MHz, Chloroform-d)δ8.01-7.92(m,1H),7.81-7.72(m,1H),7.72-7.62(m,3H),7.57-7.46(m,2H),7.37- 7.30 (m, 3H), 7.29 (dd, J=7.3, 1.5Hz, 1H), 7.22 (td, J=7.4, 1.6Hz, 1H), 7.18–7.09 (m, 2H).

实施例2:Example 2:

Figure BDA0003256636660000081
Figure BDA0003256636660000081

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000082
Figure BDA0003256636660000082

将2-氨基苯硫醇(0.75g,6mmol)和1-四氢萘酮(0.584g,4mmol),在DMSO(16.0mL)中的混合溶液在110℃下在空气中搅拌24小时。完成后,将反应混合物用乙酸乙酯(64.0mL)稀释,过滤。真空除去挥发物,得到粗产物。进一步硅胶柱色谱法(EtOAc/石油醚)分离提纯得到苯并吩噻嗪1。产率:87%。1H NMR(400MHz,Chloroform-d)δ9.58(s,2H),7.89–7.80(m,2H),7.76–7.69(m,2H),7.64(dd,J=7.4,1.5Hz,2H),7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).A mixed solution of 2-aminobenzenethiol (0.75 g, 6 mmol) and 1-tetralone (0.584 g, 4 mmol) in DMSO (16.0 mL) was stirred at 110° C. in air for 24 hours. Upon completion, the reaction mixture was diluted with ethyl acetate (64.0 mL) and filtered. The volatiles were removed in vacuo to give the crude product. Further separation and purification by silica gel column chromatography (EtOAc/petroleum ether) gave benzophenothiazine 1. Yield: 87%. 1 H NMR (400MHz, Chloroform-d) δ9.58(s, 2H), 7.89-7.80(m, 2H), 7.76-7.69(m, 2H), 7.64(dd, J=7.4, 1.5Hz, 2H) ,7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).

Figure BDA0003256636660000091
Figure BDA0003256636660000091

在圆底烧瓶中加入苯并吩噻嗪1(1.246g,5mmo1),(4-溴苯基)[双(2,4,6-三甲基苯基)]硼烷(2.424g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料2。产率:80%。1H NMR(400MHz,Chloroform-d)δ7.97–7.90(m,1H),7.78(ddd,J=7.3,2.0,1.4Hz,1H),7.73–7.64(m,3H),7.59–7.46(m,2H),7.33–7.26(m,2H),7.23–7.15(m,2H),7.15–7.08(m,3H),6.92(s,4H),2.31(d,J=0.7Hz,6H),2.25(s,12H).In a round bottom flask, add benzophenothiazine 1 (1.246g, 5mmol), (4-bromophenyl)[bis(2,4,6-trimethylphenyl)]borane (2.424g, 6mmol) , sodium tert-butoxide (2.76g, 15mmol), tris(dibenzylideneacetone)dipalladium (92mg, 0.1mmol), tri-tert-butylphosphine tetrafluoroborate (0.146g, 0.5mmol), 25mL of toluene. Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 2. Yield: 80%. 1 H NMR(400MHz, Chloroform-d)δ7.97-7.90(m,1H),7.78(ddd,J=7.3,2.0,1.4Hz,1H),7.73-7.64(m,3H),7.59-7.46( m, 2H), 7.33–7.26 (m, 2H), 7.23–7.15 (m, 2H), 7.15–7.08 (m, 3H), 6.92 (s, 4H), 2.31 (d, J=0.7Hz, 6H) ,2.25(s,12H).

实施例3:Example 3:

Figure BDA0003256636660000092
Figure BDA0003256636660000092

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000101
Figure BDA0003256636660000101

将2-氨基苯硫醇(0.75g,6mmol)和1-四氢萘酮(0.584g,4mmol),在DMSO(16.0mL)中的混合溶液在110℃下在空气中搅拌24小时。完成后,将反应混合物用乙酸乙酯(64.0mL)稀释,过滤。真空除去挥发物,得到粗产物。进一步硅胶柱色谱法(EtOAc/石油醚)分离提纯得到苯并吩噻嗪1。产率:87%。1H NMR(400MHz,Chloroform-d)δ9.58(s,2H),7.89–7.80(m,2H),7.76–7.69(m,2H),7.64(dd,J=7.4,1.5Hz,2H),7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).A mixed solution of 2-aminobenzenethiol (0.75 g, 6 mmol) and 1-tetralone (0.584 g, 4 mmol) in DMSO (16.0 mL) was stirred at 110° C. in air for 24 hours. Upon completion, the reaction mixture was diluted with ethyl acetate (64.0 mL) and filtered. The volatiles were removed in vacuo to give the crude product. Further separation and purification by silica gel column chromatography (EtOAc/petroleum ether) gave benzophenothiazine 1. Yield: 87%. 1 H NMR (400MHz, Chloroform-d) δ9.58(s, 2H), 7.89-7.80(m, 2H), 7.76-7.69(m, 2H), 7.64(dd, J=7.4, 1.5Hz, 2H) ,7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).

Figure BDA0003256636660000102
Figure BDA0003256636660000102

在圆底烧瓶中加入苯并吩噻嗪1(1.246g,5mmo1),5-溴-1,3-苯二腈(1.246g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料2。产率:80%。1H NMR(400MHz,Chloroform-d)δ7.95–7.88(m,1H),7.86(t,J=1.4Hz,1H),7.81–7.72(m,3H),7.68(dd,J=7.6,1.4Hz,1H),7.56–7.45(m,2H),7.36–7.26(m,2H),7.26–7.20(m,1H),7.20–7.13(m,1H),7.09(td,J=7.3,1.8Hz,1H).In a round-bottomed flask, add benzophenothiazine 1 (1.246g, 5mmol), 5-bromo-1,3-phthalonitrile (1.246g, 6mmol), sodium tert-butoxide (2.76g, 15mmol), tris( Dibenzylideneacetone) dipalladium (92 mg, 0.1 mmol), tri-tert-butylphosphine tetrafluoroborate (0.146 g, 0.5 mmol), 25 mL of toluene. Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 2. Yield: 80%. 1 H NMR(400MHz, Chloroform-d)δ7.95-7.88(m,1H),7.86(t,J=1.4Hz,1H),7.81-7.72(m,3H),7.68(dd,J=7.6, 1.4Hz, 1H), 7.56–7.45 (m, 2H), 7.36–7.26 (m, 2H), 7.26–7.20 (m, 1H), 7.20–7.13 (m, 1H), 7.09 (td, J=7.3, 1.8Hz, 1H).

实施例4:Example 4:

Figure BDA0003256636660000111
Figure BDA0003256636660000111

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000112
Figure BDA0003256636660000112

将2-氨基苯硫醇(0.75g,6mmol)和1-四氢萘酮(0.584g,4mmol),在DMSO(16.0mL)中的混合溶液在110℃下在空气中搅拌24小时。完成后,将反应混合物用乙酸乙酯(64.0mL)稀释,过滤。真空除去挥发物,得到粗产物。进一步硅胶柱色谱法(EtOAc/石油醚)分离提纯得到苯并吩噻嗪1。产率:87%。1H NMR(400MHz,Chloroform-d)δ9.58(s,2H),7.89–7.80(m,2H),7.76–7.69(m,2H),7.64(dd,J=7.4,1.5Hz,2H),7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).A mixed solution of 2-aminobenzenethiol (0.75 g, 6 mmol) and 1-tetralone (0.584 g, 4 mmol) in DMSO (16.0 mL) was stirred at 110° C. in air for 24 hours. Upon completion, the reaction mixture was diluted with ethyl acetate (64.0 mL) and filtered. The volatiles were removed in vacuo to give the crude product. Further separation and purification by silica gel column chromatography (EtOAc/petroleum ether) gave benzophenothiazine 1. Yield: 87%. 1 H NMR (400MHz, Chloroform-d) δ9.58(s, 2H), 7.89-7.80(m, 2H), 7.76-7.69(m, 2H), 7.64(dd, J=7.4, 1.5Hz, 2H) ,7.53–7.42(m,4H),7.29(dd,J=7.4,0.5Hz,2H),7.19–7.15(m,1H),7.15–7.01(m,7H).

Figure BDA0003256636660000121
Figure BDA0003256636660000121

在圆底烧瓶中加入苯并吩噻嗪1(1.246g,5mmo1),2-4-溴苯基-4,6-二苯基-1,3,5-三嗪(2.329g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料2。产率:80%。1H NMR(400MHz,Chloroform-d)δ8.61–8.50(m,4H),8.09–8.02(m,2H),7.94(dd,J=7.1,1.7Hz,1H),7.78(dt,J=7.6,1.7Hz,1H),7.69(dd,J=7.5,1.5Hz,1H),7.59–7.51(m,2H),7.51–7.48(m,3H),7.48–7.36(m,5H),7.34–7.26(m,2H),7.23–7.13(m,2H),7.07(ddd,J=7.5,6.7,2.4Hz,1H).In a round bottom flask, add benzophenothiazine 1 (1.246g, 5mmol), 2-4-bromophenyl-4,6-diphenyl-1,3,5-triazine (2.329g, 6mmol), Sodium tert-butoxide (2.76g, 15mmol), tris(dibenzylideneacetone)dipalladium (92mg, 0.1mmol), tri-tert-butylphosphine tetrafluoroborate (0.146g, 0.5mmol), toluene 25mL. Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 2. Yield: 80%. 1 H NMR (400MHz, Chloroform-d) δ 8.61-8.50 (m, 4H), 8.09-8.02 (m, 2H), 7.94 (dd, J=7.1, 1.7Hz, 1H), 7.78 (dt, J= 7.6, 1.7Hz, 1H), 7.69 (dd, J=7.5, 1.5Hz, 1H), 7.59–7.51 (m, 2H), 7.51–7.48 (m, 3H), 7.48–7.36 (m, 5H), 7.34 –7.26(m,2H),7.23–7.13(m,2H),7.07(ddd,J=7.5,6.7,2.4Hz,1H).

实施例5:Example 5:

Figure BDA0003256636660000122
Figure BDA0003256636660000122

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000131
Figure BDA0003256636660000131

在250毫升圆底烧瓶中,加入化合物1(1.35g,5mmol)、硫(0.32g,5mmol)和碘(0.33g,1.3mmol)。将反应混合物升至180-185℃,并在该温度下保持25分钟,然后冷却至室温。将深色反应物质溶解在少量丙酮中添加足够的石油醚以产生两层。分离各层后,用新鲜的温热石油醚数次萃取深色溶液,并将石油醚层合并。溶剂蒸发后生成黄棕色结晶固体,从正辛烷中结晶得到苯并吩噻嗪配合物2。产率;70%。1H NMR(400MHz,Chloroform-d)δ7.94–7.84(m,1H),7.76–7.66(m,2H),7.53–7.41(m,2H),7.34(dd,J=7.4,0.6Hz,1H).In a 250 mL round bottom flask, compound 1 (1.35 g, 5 mmol), sulfur (0.32 g, 5 mmol) and iodine (0.33 g, 1.3 mmol) were added. The reaction mixture was raised to 180-185°C and held at this temperature for 25 minutes, then cooled to room temperature. The dark reaction mass was dissolved in a small amount of acetone and enough petroleum ether was added to produce two layers. After separation of the layers, the dark solution was extracted several times with fresh warm petroleum ether and the petroleum ether layers were combined. After evaporation of the solvent, a yellow-brown crystalline solid was formed, which was crystallized from n-octane to give the benzophenothiazine complex 2. Yield; 70%. 1 H NMR (400MHz, Chloroform-d)δ7.94-7.84(m,1H),7.76-7.66(m,2H),7.53-7.41(m,2H),7.34(dd,J=7.4,0.6Hz, 1H).

Figure BDA0003256636660000132
Figure BDA0003256636660000132

在圆底烧瓶中加入苯并吩噻嗪配合物2(1.49g,5mmo1),4-溴苯腈(1.092g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料3。产率:80%。1H NMR(400MHz,Chloroform-d)δ7.97–7.88(m,1H),7.80–7.73(m,1H),7.72–7.63(m,2H),7.57–7.46(m,2H),7.37–7.29(m,2H).In a round-bottomed flask, add benzophenothiazine complex 2 (1.49g, 5mmol), 4-bromobenzonitrile (1.092g, 6mmol), sodium tert-butoxide (2.76g, 15mmol), tris(dibenzylidene) acetone) dipalladium (92 mg, 0.1 mmol), tri-tert-butylphosphine tetrafluoroborate (0.146 g, 0.5 mmol), 25 mL of toluene. Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 3. Yield: 80%. 1 H NMR (400MHz, Chloroform-d)δ7.97-7.88(m,1H),7.80-7.73(m,1H),7.72-7.63(m,2H),7.57-7.46(m,2H),7.37- 7.29(m,2H).

实施例6:Example 6:

Figure BDA0003256636660000141
Figure BDA0003256636660000141

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000142
Figure BDA0003256636660000142

在250毫升圆底烧瓶中,加入化合物1(1.35g,5mmol)、硫(0.32g,5mmol)和碘(0.33g,1.3mmol)。将反应混合物升至180-185℃,并在该温度下保持25分钟,然后冷却至室温。将深色反应物质溶解在少量丙酮中添加足够的石油醚以产生两层。分离各层后,用新鲜的温热石油醚数次萃取深色溶液,并将石油醚层合并。溶剂蒸发后生成黄棕色结晶固体,从正辛烷中结晶得到苯并吩噻嗪配合物2。产率;70%。1H NMR(400MHz,Chloroform-d)δ7.94–7.84(m,1H),7.76–7.66(m,2H),7.53–7.41(m,2H),7.34(dd,J=7.4,0.6Hz,1H).In a 250 mL round bottom flask, compound 1 (1.35 g, 5 mmol), sulfur (0.32 g, 5 mmol) and iodine (0.33 g, 1.3 mmol) were added. The reaction mixture was raised to 180-185°C and held at this temperature for 25 minutes, then cooled to room temperature. The dark reaction mass was dissolved in a small amount of acetone and enough petroleum ether was added to produce two layers. After separation of the layers, the dark solution was extracted several times with fresh warm petroleum ether and the petroleum ether layers were combined. After evaporation of the solvent, a yellow-brown crystalline solid was formed, which was crystallized from n-octane to give the benzophenothiazine complex 2. Yield; 70%. 1 H NMR (400MHz, Chloroform-d)δ7.94-7.84(m,1H),7.76-7.66(m,2H),7.53-7.41(m,2H),7.34(dd,J=7.4,0.6Hz, 1H).

Figure BDA0003256636660000151
Figure BDA0003256636660000151

在圆底烧瓶中加入苯并吩噻嗪配合物2(1.49g,5mmo1),化合物(4-溴苯基)[双(2,4,6-三甲基苯基)]硼烷(2.424g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料3。产率:80%。1H NMR(400MHz,Chloroform-d)δ7.94(dd,J=7.3,1.9Hz,1H),7.78(dt,J=7.1,1.7Hz,1H),7.73–7.64(m,2H),7.58–7.46(m,2H),7.27(dd,J=7.5,0.5Hz,1H),7.18–7.11(m,1H),6.91(s,2H),2.31(d,J=0.7Hz,3H),2.25(s,6H).In a round bottom flask, add benzophenothiazine complex 2 (1.49g, 5mmol), compound (4-bromophenyl)[bis(2,4,6-trimethylphenyl)]borane (2.424g) , 6mmol), sodium tert-butoxide (2.76g, 15mmol), tris(dibenzylideneacetone)dipalladium (92mg, 0.1mmol), tri-tert-butylphosphine tetrafluoroborate (0.146g, 0.5mmol), toluene 25mL . Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 3. Yield: 80%. 1 H NMR (400 MHz, Chloroform-d) δ 7.94 (dd, J=7.3, 1.9 Hz, 1H), 7.78 (dt, J=7.1, 1.7 Hz, 1H), 7.73-7.64 (m, 2H), 7.58 –7.46(m,2H),7.27(dd,J=7.5,0.5Hz,1H),7.18–7.11(m,1H),6.91(s,2H),2.31(d,J=0.7Hz,3H), 2.25(s,6H).

实施例7:Example 7:

Figure BDA0003256636660000152
Figure BDA0003256636660000152

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000153
Figure BDA0003256636660000153

在250毫升圆底烧瓶中,加入化合物1(1.35g,5mmol)、硫(0.32g,5mmol)和碘(0.33g,1.3mmol)。将反应混合物升至180-185℃,并在该温度下保持25分钟,然后冷却至室温。将深色反应物质溶解在少量丙酮中添加足够的石油醚以产生两层。分离各层后,用新鲜的温热石油醚数次萃取深色溶液,并将石油醚层合并。溶剂蒸发后生成黄棕色结晶固体,从正辛烷中结晶得到苯并吩噻嗪配合物2。产率;70%。1H NMR(400MHz,Chloroform-d)δ7.94–7.84(m,1H),7.76–7.66(m,2H),7.53–7.41(m,2H),7.34(dd,J=7.4,0.6Hz,1H).In a 250 mL round bottom flask, compound 1 (1.35 g, 5 mmol), sulfur (0.32 g, 5 mmol) and iodine (0.33 g, 1.3 mmol) were added. The reaction mixture was raised to 180-185°C and held at this temperature for 25 minutes, then cooled to room temperature. The dark reaction mass was dissolved in a small amount of acetone and enough petroleum ether was added to produce two layers. After separation of the layers, the dark solution was extracted several times with fresh warm petroleum ether and the petroleum ether layers were combined. After evaporation of the solvent, a yellow-brown crystalline solid was formed, which was crystallized from n-octane to give the benzophenothiazine complex 2. Yield; 70%. 1 H NMR (400MHz, Chloroform-d)δ7.94-7.84(m,1H),7.76-7.66(m,2H),7.53-7.41(m,2H),7.34(dd,J=7.4,0.6Hz, 1H).

Figure BDA0003256636660000161
Figure BDA0003256636660000161

在圆底烧瓶中加入苯并吩噻嗪配合物2(1.49g,5mmo1),化合物5-溴-1,3-苯二腈(1.246g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料3。产率:80%。1H NMR(400MHz,Chloroform-d)δ7.95–7.86(m,4H),7.85(t,J=1.4Hz,2H),7.81–7.77(m,1H),7.77–7.68(m,11H),7.55–7.46(m,8H),7.39–7.32(m,4H).Add benzophenothiazine complex 2 (1.49g, 5mmol), compound 5-bromo-1,3-phthalonitrile (1.246g, 6mmol), sodium tert-butoxide (2.76g, 15mmol) to a round bottom flask , tris(dibenzylideneacetone)dipalladium (92mg, 0.1mmol), tri-tert-butylphosphine tetrafluoroborate (0.146g, 0.5mmol), toluene 25mL. Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 3. Yield: 80%. 1 H NMR(400MHz, Chloroform-d)δ7.95-7.86(m,4H),7.85(t,J=1.4Hz,2H),7.81-7.77(m,1H),7.77-7.68(m,11H) ,7.55–7.46(m,8H),7.39–7.32(m,4H).

实施例8:Example 8:

Figure BDA0003256636660000171
Figure BDA0003256636660000171

合成路线如下所示:The synthetic route is as follows:

Figure BDA0003256636660000172
Figure BDA0003256636660000172

在250毫升圆底烧瓶中,加入化合物1(1.35g,5mmol)、硫(0.32g,5mmol)和碘(0.33g,1.3mmol)。将反应混合物升至180-185℃,并在该温度下保持25分钟,然后冷却至室温。将深色反应物质溶解在少量丙酮中添加足够的石油醚以产生两层。分离各层后,用新鲜的温热石油醚数次萃取深色溶液,并将石油醚层合并。溶剂蒸发后生成黄棕色结晶固体,从正辛烷中结晶得到苯并吩噻嗪配合物2。产率;70%。1H NMR(400MHz,Chloroform-d)δ7.94–7.84(m,1H),7.76–7.66(m,2H),7.53–7.41(m,2H),7.34(dd,J=7.4,0.6Hz,1H).In a 250 mL round bottom flask, compound 1 (1.35 g, 5 mmol), sulfur (0.32 g, 5 mmol) and iodine (0.33 g, 1.3 mmol) were added. The reaction mixture was raised to 180-185°C and held at this temperature for 25 minutes, then cooled to room temperature. The dark reaction mass was dissolved in a small amount of acetone and enough petroleum ether was added to produce two layers. After separation of the layers, the dark solution was extracted several times with fresh warm petroleum ether and the petroleum ether layers were combined. After evaporation of the solvent, a yellow-brown crystalline solid was formed, which was crystallized from n-octane to give the benzophenothiazine complex 2. Yield; 70%. 1 H NMR (400MHz, Chloroform-d)δ7.94-7.84(m,1H),7.76-7.66(m,2H),7.53-7.41(m,2H),7.34(dd,J=7.4,0.6Hz, 1H).

Figure BDA0003256636660000173
Figure BDA0003256636660000173

在圆底烧瓶加入苯并吩噻嗪配合物2(1.49g,5mmo1),2-4-溴苯基-4,6-二苯基-1,3,5-三嗪(2.329g,6mmo1),叔丁醇钠(2.76g,15mmo1),三(二亚苄基丙酮)二钯(92mg,0.1mmo1),四氟硼酸三叔丁基膦(0.146g,0.5mmo1),甲苯25mL。氮气保护下,搅拌使之溶解,升温至回流,反应13h后停止。用二氯甲烷萃取三次,无水硫酸钠干燥。柱层析分离,得到苯并吩噻嗪延迟荧光发光材料3。产率:80%。1H NMR(400MHz,Chloroform-d)δ8.60–8.51(m,2H),8.05–7.98(m,1H),7.96–7.86(m,1H),7.83–7.74(m,1H),7.68(dd,J=7.4,1.5Hz,1H),7.56–7.42(m,5H),7.40–7.33(m,1H),7.27(d,J=7.5Hz,1H).In a round bottom flask, add benzophenothiazine complex 2 (1.49g, 5mmol), 2-4-bromophenyl-4,6-diphenyl-1,3,5-triazine (2.329g, 6mmol) , sodium tert-butoxide (2.76g, 15mmol), tris(dibenzylideneacetone)dipalladium (92mg, 0.1mmol), tri-tert-butylphosphine tetrafluoroborate (0.146g, 0.5mmol), 25mL of toluene. Under the protection of nitrogen, the mixture was stirred to dissolve, heated to reflux, and the reaction was stopped after 13 h. It was extracted three times with dichloromethane and dried over anhydrous sodium sulfate. Column chromatography separation to obtain benzophenothiazine delayed fluorescence luminescent material 3. Yield: 80%. 1 H NMR (400MHz, Chloroform-d)δ8.60-8.51(m,2H),8.05-7.98(m,1H),7.96-7.86(m,1H),7.83-7.74(m,1H),7.68( dd, J=7.4, 1.5Hz, 1H), 7.56–7.42 (m, 5H), 7.40–7.33 (m, 1H), 7.27 (d, J=7.5Hz, 1H).

材料性质测试Material property testing

1、光谱测试:1. Spectral test:

选取实施例3、实施例4制备的苯并吩噻嗪衍生物进行光谱测试,实施例3中的苯并吩噻嗪衍生物的吸收光谱和发射光谱分别如图1和图3所示,实施例4的苯并吩噻嗪衍生物的吸收光谱和发射光谱分别如图2和图4所示。The benzophenothiazine derivatives prepared in Example 3 and Example 4 were selected for spectral testing. The absorption spectrum and emission spectrum of the benzophenothiazine derivatives in Example 3 were shown in Figure 1 and Figure 3, respectively. The absorption spectrum and the emission spectrum of the benzophenothiazine derivative of Example 4 are shown in Fig. 2 and Fig. 4, respectively.

由图3和图4可以看出,本发明所合成的苯并吩噻嗪衍生物具有较高的发光效率,可以应用于有机电致发光器件中。It can be seen from FIG. 3 and FIG. 4 that the benzophenothiazine derivatives synthesized in the present invention have high luminous efficiency and can be applied to organic electroluminescent devices.

2、TGA测试:2. TGA test:

测试本发明实施例1-8中所制备的各苯并吩噻嗪衍生物的热失重温度,测试结果如下表1所示。The thermal weight loss temperature of each benzophenothiazine derivative prepared in Examples 1-8 of the present invention was tested, and the test results are shown in Table 1 below.

注:热失重温度是在氮气气氛中失重5%的温度。Note: The thermogravimetric temperature is the temperature at which 5% of the weight is lost in a nitrogen atmosphere.

表1Table 1

Figure BDA0003256636660000191
Figure BDA0003256636660000191

由上述数据可知,本发明所合成的苯并吩噻嗪衍生物的热稳定性优良,可以满足有机电致发光材料使用的要求。From the above data, it can be known that the benzophenothiazine derivatives synthesized by the present invention have excellent thermal stability and can meet the requirements for the use of organic electroluminescent materials.

以上已以较佳实施例公布了本发明,然其并非用以限制本发明,凡采取等同替换或等效变换的方案所获得的技术方案,均落在本发明的保护范围内。The present invention has been disclosed above with preferred embodiments, but it is not intended to limit the present invention, and all technical solutions obtained by adopting equivalent replacement or equivalent transformation schemes all fall within the protection scope of the present invention.

Claims (7)

1.一种苯并吩噻嗪衍生物,其特征在于,其结构通式如下式a或b所示:1. a benzophenothiazine derivative, is characterized in that, its general structural formula is shown in following formula a or b:
Figure FDA0003256636650000011
Figure FDA0003256636650000011
其中,
Figure FDA0003256636650000012
选自以下结构式中的任一种:
in,
Figure FDA0003256636650000012
is selected from any one of the following structural formulas:
Figure FDA0003256636650000013
Figure FDA0003256636650000013
2.根据权利要求1所述的一种苯并吩噻嗪衍生物的制备方法,其特征在于,以苯并吩噻嗪作为电子供体单元,与电子受体单元在吩噻嗪的氮原子上发生共价键接合,所述电子受体单元选自4-溴苯腈、(4-溴苯基)[双(2,4,6-三甲基苯基)]硼烷、5-溴-1,3-苯二腈、2-4-溴苯基-4,6-二苯基-1,3,5-三嗪中的任一种。2. the preparation method of a kind of benzophenothiazine derivative according to claim 1 is characterized in that, with benzophenothiazine as electron donor unit, and electron acceptor unit in the nitrogen atom of phenothiazine Covalent bonding occurs on the electron acceptor unit selected from 4-bromobenzonitrile, (4-bromophenyl)[bis(2,4,6-trimethylphenyl)]borane, 5-bromophenyl -1,3-phthalonitrile and 2-4-bromophenyl-4,6-diphenyl-1,3,5-triazine. 3.根据权利要求2所述的制备方法,其特征在于,所述电子供体单元为
Figure FDA0003256636650000014
3. preparation method according to claim 2, is characterized in that, described electron donor unit is
Figure FDA0003256636650000014
4.权利要求1中式a所示苯并吩噻嗪衍生物的制备方法,其特征在于,合成路线如下:4. the preparation method of benzophenothiazine derivative shown in formula a in claim 1, is characterized in that, synthetic route is as follows:
Figure FDA0003256636650000021
Figure FDA0003256636650000021
其中,
Figure FDA0003256636650000022
为以下结构式中的任一种:
in,
Figure FDA0003256636650000022
is any of the following structural formulas:
Figure FDA0003256636650000023
Figure FDA0003256636650000023
5.根据权利要求4所述的制备方法,其特征在于,包括以下步骤:5. preparation method according to claim 4, is characterized in that, comprises the following steps: 将2-氨基苯硫醇和1-四氢萘酮溶解在二甲基亚砜中,在110℃下反应24h后提纯得到相应的苯并吩噻嗪配合物1;The corresponding benzophenothiazine complex 1 was obtained by dissolving 2-aminobenzenethiol and 1-tetralone in dimethyl sulfoxide and reacting at 110 °C for 24 h after purification; 将苯并吩噻嗪配合物1、化合物
Figure FDA0003256636650000024
叔丁醇钠、三(二亚苄基丙酮)二钯、四氟硼酸三叔丁基膦溶解于甲苯中,在氮气保护下反应13h后分离提纯得到。
The benzophenothiazine complex 1, compound
Figure FDA0003256636650000024
Sodium tert-butoxide, tris(dibenzylideneacetone)dipalladium and tri-tert-butylphosphine tetrafluoroborate were dissolved in toluene, reacted under nitrogen protection for 13h, and obtained by separation and purification.
6.权利要求1中式b所示苯并吩噻嗪衍生物的制备方法,其特征在于,合成路线如下:6. the preparation method of benzophenothiazine derivative shown in formula b in claim 1, is characterized in that, synthetic route is as follows:
Figure FDA0003256636650000031
Figure FDA0003256636650000031
其中,
Figure FDA0003256636650000032
为以下结构式中的任一种:
in,
Figure FDA0003256636650000032
is any of the following structural formulas:
Figure FDA0003256636650000033
Figure FDA0003256636650000033
7.根据权利要求6所述的制备方法,其特征在于,包括以下步骤:7. preparation method according to claim 6, is characterized in that, comprises the following steps: 将化合物1、硫和碘混合物加热至180-185℃,在该温度反应25分钟分离提纯得到相应的苯并吩噻嗪配合物2;Compound 1, sulfur and iodine mixture are heated to 180-185°C, and react at this temperature for 25 minutes to separate and purify to obtain the corresponding benzophenothiazine complex 2; 将苯并吩噻嗪配合物2、化合物
Figure FDA0003256636650000034
叔丁醇钠、三(二亚苄基丙酮)二钯,四氟硼酸三叔丁基膦溶解于甲苯中,在氮气保护下反应13h后分析提纯得到。
The benzophenothiazine complex 2, compound
Figure FDA0003256636650000034
Sodium tert-butoxide, tris(dibenzylideneacetone)dipalladium, and tri-tert-butylphosphine tetrafluoroborate were dissolved in toluene, reacted for 13h under nitrogen protection, and obtained by analysis and purification.
CN202111061758.2A 2021-09-10 2021-09-10 Benzophenothiazine derivatives and process for their preparation Withdrawn CN113845491A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111061758.2A CN113845491A (en) 2021-09-10 2021-09-10 Benzophenothiazine derivatives and process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111061758.2A CN113845491A (en) 2021-09-10 2021-09-10 Benzophenothiazine derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
CN113845491A true CN113845491A (en) 2021-12-28

Family

ID=78973563

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111061758.2A Withdrawn CN113845491A (en) 2021-09-10 2021-09-10 Benzophenothiazine derivatives and process for their preparation

Country Status (1)

Country Link
CN (1) CN113845491A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115772139A (en) * 2022-11-29 2023-03-10 南京邮电大学 2, 3-benzophenothiazine derivative, preparation method and application
CN115850260A (en) * 2022-11-28 2023-03-28 郑州大学 Twisted lanthanide series metal europium supramolecular cage complex, preparation method and application

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109053632A (en) * 2018-09-30 2018-12-21 长春海谱润斯科技有限公司 A kind of fluorene kind derivative and its organic electroluminescence device
CN110167940A (en) * 2017-01-30 2019-08-23 默克专利有限公司 Material for organic electroluminescence device
CN111484514A (en) * 2019-01-29 2020-08-04 三星显示有限公司 Organic electroluminescent device and polycyclic compound for organic electroluminescent device
CN112142605A (en) * 2019-06-28 2020-12-29 北京鼎材科技有限公司 Compound, application thereof and organic electroluminescent device comprising compound
CN113321628A (en) * 2021-05-28 2021-08-31 南京邮电大学 N-type organic dye based on benzothiazol and preparation method and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167940A (en) * 2017-01-30 2019-08-23 默克专利有限公司 Material for organic electroluminescence device
CN109053632A (en) * 2018-09-30 2018-12-21 长春海谱润斯科技有限公司 A kind of fluorene kind derivative and its organic electroluminescence device
CN111484514A (en) * 2019-01-29 2020-08-04 三星显示有限公司 Organic electroluminescent device and polycyclic compound for organic electroluminescent device
CN112142605A (en) * 2019-06-28 2020-12-29 北京鼎材科技有限公司 Compound, application thereof and organic electroluminescent device comprising compound
CN113321628A (en) * 2021-05-28 2021-08-31 南京邮电大学 N-type organic dye based on benzothiazol and preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIN YA-MEI等: "Radical Route to 1,4-Benzothiazine Derivatives from 2‑Aminobenzenethiols and Ketones under Transition-Metal-Free Conditions", 《ORGANIC LETTERS》 *
MADRID PETER B.等: "Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115850260A (en) * 2022-11-28 2023-03-28 郑州大学 Twisted lanthanide series metal europium supramolecular cage complex, preparation method and application
CN115850260B (en) * 2022-11-28 2025-04-01 郑州大学 Twisted lanthanide metal europium supramolecular cage complex, preparation method and application
CN115772139A (en) * 2022-11-29 2023-03-10 南京邮电大学 2, 3-benzophenothiazine derivative, preparation method and application

Similar Documents

Publication Publication Date Title
CN105061371B (en) Aromatic amine derivatives and organic electroluminescent devices
CN106588674A (en) Organic electroluminescent device and material thereof
KR101356953B1 (en) Carbazole derivatives and organic light emitting device using the same
CN109748909A (en) A compound containing spiroxanthene fluorene and nitrogen-containing six-membered heterocyclic ring, its preparation method and its application in organic electroluminescent devices
CN110759937A (en) Boron-containing organic electroluminescent compound and preparation method and application thereof
CN108586353A (en) A kind of luminous organic material and its preparation method and application based on anthracene and its derivative
CN114478499B (en) A spirofluorene anthracene compound and its application
KR102422398B1 (en) Fused polycyclic compound, and preparation method and use thereof
CN114149431B (en) A narrow emission quinacridone derivative and its preparation method and application
CN113845491A (en) Benzophenothiazine derivatives and process for their preparation
CN113549059A (en) Organic compound, and electronic device and electronic apparatus comprising same
CN115884962A (en) Method for preparing deuterated aromatic compounds and deuterated reaction compositions
CN113816935A (en) Nitrogen-containing compound, electronic component, and electronic device
CN116326249A (en) Method for preparing deuterated aromatic compounds and deuterated reaction compositions
KR101548370B1 (en) Anthracene derivative and organic electroluminescent device including the same
CN109574996A (en) It is a kind of using spiral shell xanthene fluorenes as the compound of core and its application on organic electroluminescence device
CN115477612B (en) A method for synthesizing spiro-substituted acridine compounds and their application
CN107868049A (en) Organic compound and organic electroluminescence device using the fluorenes of 9,9 ' spiral shell two as core
CN109574908A (en) A kind of compound of the fluorenes of dimethylanthracene containing spiral shell and its application on organic electroluminescence device
CN115073477B (en) A kind of carbazole derivative and its preparation method and optoelectronic device
CN111747894A (en) A compound with a dibenzo nitrogen-containing six-membered heterocycle as the core and its application in organic electroluminescent devices
CN115772139A (en) 2, 3-benzophenothiazine derivative, preparation method and application
JP7427318B2 (en) Novel compounds and organic light-emitting devices using them
CN104629719B (en) Fluorene derivatives and applications thereof in electroluminescent devices
CN107868051A (en) A kind of organic compound containing fluorenes and preparation method thereof and applied on organic electroluminescence device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20211228